No Time To Cry: New Bond movie could reportedly lose up to $100million through Covid-related delays despite becoming highest grossing Hollywood film this year
- No Time To Die could lose up to £75million due to the pandemic, it is claimed
- Daniel Craig’ final outing as James Bond is still best performing film since Covid
- But it needed around £673million in takings to break even, according to Variety
James Bond may have found a mission even he can’t complete.
Despite becoming the highest grossing Hollywood film this year, No Time To Die could reportedly lose up to $100million (£75million).
The film, which marked Daniel Craig’s final outing as 007, grossed more than £545million at the global box office to become the best performing film since the start of the pandemic.
But at a reported cost of more than £187million to produce, at least £75million to promote and an alleged tens of millions more to postpone, it would have needed to make close to £673million to break even, according to Variety magazine.
Nomi (Lashana Lynch) and James Bond (Daniel Craig) star in No Time To Die
As a result it reportedly looks set to lose £75million.
Metro Goldwyn Mayer, the studio behind the film, vehemently denied the claims.
‘Unnamed and uninformed sources suggesting the film will lose money are categorically unfounded and put more simply, not true,’ a statement read.
MGM said the film had ‘far exceeded our theatrical estimates in this time frame’ and claimed it ‘will earn a profit for MGM, both as an individual film title and as part of MGM’s incredible library’.
The spy blockbuster was plagued by delays owing to the pandemic, with producers swerving streaming platforms in favour of holding out for a cinema release.
The long-awaited film, which was scheduled for November 2019 finally hit the big screen in September.
It broke the record for the widest theatrical release of all-time in the UK with 772 cinemas playing the film – 25 more than the previous record-holder Star Wars: Rise Of Skywalker in 2019.